Nano-Microparticle Platforms in Developing Next-Generation Vaccines

Nano-Microparticle Platforms in Developing Next-Generation Vaccines

The first vaccines ever made were based on live-attenuated or inactivated pathogens, either whole cells or fragments. Although these vaccines required the co-administration of antigens with adjuvants to induce a strong humoral response, they could only elicit a poor CD8<sup>+</sup> T-cel...

Full description

Bibliographic Details
Main Authors: Giuseppe Cappellano, Hugo Abreu, Chiara Casale, Umberto Dianzani, Annalisa Chiocchetti
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Vaccines
Subjects:
advanced vaccines
PLGA
liposome
extracellular vesicles
virus infection
Online Access:https://www.mdpi.com/2076-393X/9/6/606

Similar Items

Similar Items